Have a personal or library account? Click to login
Liquid chromatography–mass spectrometry analysis of carvacrol in chicken tissues Cover

Liquid chromatography–mass spectrometry analysis of carvacrol in chicken tissues

Open Access
|Jun 2022

Figures & Tables

Fig. 1

Chromatograms obtained during validation. cps – counts per second; A and B – blank muscle sample; C and D – blank muscle sample containing carvacrol at the limit of quantification; E – internal standard
Chromatograms obtained during validation. cps – counts per second; A and B – blank muscle sample; C and D – blank muscle sample containing carvacrol at the limit of quantification; E – internal standard

Fig. 2

The proposed carvacrol fragmentation path
The proposed carvacrol fragmentation path

Fig. 3

Mass spectra of carvacrol at different collision energies. A – collision energy − 30 V; B – collision energy − 45 V; C – collision energy − 15 V
Mass spectra of carvacrol at different collision energies. A – collision energy − 30 V; B – collision energy − 45 V; C – collision energy − 15 V

Fig. 4

Chromatograms obtained during optimisation. A – Muscle sample containing carvacrol at a 10 μg g−1 concentration in negative-ion electrospray ionisation mode; B – Muscle sample containing carvacrol at a 10 μg g−1 concentration in negative-ion atmospheric pressure chemical ionisation mode
Chromatograms obtained during optimisation. A – Muscle sample containing carvacrol at a 10 μg g−1 concentration in negative-ion electrospray ionisation mode; B – Muscle sample containing carvacrol at a 10 μg g−1 concentration in negative-ion atmospheric pressure chemical ionisation mode

Fig. 5

Comparison of suitability of different extraction solvents for carvacrol
Comparison of suitability of different extraction solvents for carvacrol

Parameters obtained for the calibration curves during validation

Concentration (μg g−1)Repeatability (RSDr,%) (n = 6)Within-lab reproducibility (RSDwR,%) (n = 18)Expanded uncertainty (μg g−1)Apparent recovery (%)
Lung
0.23.8 ± 4.65.6 ± 4.4-103.9 ± 4.3
1.03.7 ± 3.64.8 ± 4.11.0 ± 0.27107.7 ± 2.4
5.02.8 ± 2.93.2 ± 3.6-101.1 ± 2.5
20.03.2 ± 3.44.7 ± 3.6-104.9 ± 4.3
50.02.9 ± 3.24.9 ± 3.1-103.1 ± 4.3
Plasma
0.24.1 ± 3.65.1 ± 4.1-102.6 ± 5.1
1.03.6 ± 3.04.3 ± 4.21.0 ± 0.23102.7 ± 3.4
5.03.8 ± 2.93.4 ± 3.3-103.1 ± 2.7
20.03.2 ± 3.74.0 ± 3.6-102.6 ± 5.1
50.04.1 ± 2.94.7 ± 3.2-103.6 ± 2.3
Liver
0.25.8 ± 4.36.3 ± 4.6-106.2 ± 7.8
1.04.9 ± 3.75.2 ± 4.31.0 ± 0.34104.7 ± 4.1
5.03.8 ± 3.93.8 ± 3.7-104.1 ± 4.3
20.04.2 ± 3.04.7 ± 4.3-106.2 ± 3.8
50.03.7 ± 3.64.2 ± 3.1-103.2 ± 4.3
Muscle
0.23.8 ± 4.54.6 ± 4.0-98.9 ± 3.0
1.03.6 ± 3.34.1 ± 3.71.0 ± 0.26103.2 ± 3.4
5.02.8 ± 3.83.7 ± 3.2-105.1 ± 3.1
20.03.2 ± 3.44.0 ± 3.2-99.9 ± 3.9
50.03.7 ± 2.94.1 ± 3.6-103.6 ± 3.5

Parameters for the multiple reaction monitoring of carvacrol

CompoundPrecursor ion (m/z)Product ion (m/z)DP (V)EP (V)CE (V)CXP (V)
Carvacrol149.0134.0−55−10−22−9
133.0−55−10−38−17
Fipronil-13C4 (IS)438.8333.8−130−10−22−37

Validation report for carvacrol

MatrixLOD (μg g−1)LOQ (μg g−1)Matrix effect (%)Working range (μg g−1)Determination coefficientCalibration curve
Lung0.060.24.5 ± 1.9%0.2–50.00.985y = 0.025x + 0.04
Plasma0.060.24.3 ± 2.7%0.2–50.00.982y = 0.065x + 0.03
Liver0.060.26.4 ± 3.6%0.2–50.00.980y = 0.355x + 0.01
Muscle0.060.23.3 ± 2.4%0.2–50.00.991y = 0.048x + 0.03
Language: English
Page range: 225 - 233
Submitted on: Mar 14, 2022
|
Accepted on: May 24, 2022
|
Published on: Jun 7, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Tomasz Śniegocki, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.